Ibrutinib and Clopidogrel (Plavix 75 mg): interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Anticoagulant or antiplatelet activity can add to ibrutinib-associated bleeding risk.
Clinical significance and safety
Ibrutinib with Clopidogrel (Plavix 75 mg) needs an individual assessment of major bleeding risk and treatment benefit, with close monitoring when both are needed. This is not a statement that all antithrombotic combinations are automatically contraindicated. Seek urgent help for black stools, vomiting blood or bleeding that will not stop, and do not independently stop prescribed medicines.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.